Flunoxaprofen, a new non-steroidal anti-inflammatory drug, does not interfere with prostaglandin synthesis in rat gastric mucosa

Pharmacol Res. 1989 Mar-Apr;21(2):177-82. doi: 10.1016/1043-6618(89)90236-3.

Abstract

The anti-inflammatory activity and the eicosanoid generation in rat gastric mucosa after a single oral dose of S-(+)-2(4-fluorophenyl)-alpha-methyl-5-benzoxazolacetic acid (flunoxaprofen, 10 mg/kg) or indomethacin (5 mg/kg) were compared. The two compounds, at the dose used, show a similar degree of anti-inflammatory activity (50% inhibition of carrageenan-induced oedema in rat paw). Moreover flunoxaprofen does not modify the formation of 6-keto-PGF1 alpha by rat gastric mucosa in vitro while indomethacin causes 50% inhibition of gastric cyclooxygenase activity. This biochemical change induced by indomethacin is associated with gastric lesions. Chronic treatment of rats with flunoxaprofen (5 or 50 mg/kg p.o. for 15 days) shows an anti-inflammatory activity in the range of 60-70% inhibition in the rat paw oedema test without gastric mucosa damages and prostaglandin synthesis inhibition.

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / metabolism
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Benzoxazoles / pharmacology*
  • Dinoprostone / metabolism
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / metabolism*
  • Indomethacin / pharmacology
  • Male
  • Prostaglandins / biosynthesis*
  • Rats
  • Rats, Inbred Strains

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzoxazoles
  • Prostaglandins
  • 6-Ketoprostaglandin F1 alpha
  • Dinoprostone
  • flunoxaprofen
  • Indomethacin